AC Immune SA expected to post a loss of 25 rappen a share - Earnings Preview

AC Immune SA

14/03/2023 11:06

* AC Immune SA  ACIU.OQ   ACIU.O  is expected to show a rise
in
quarterly revenue when it reports  results on March 16. 
    * The Lausanne Vaud-based  company is expected to report
revenue
of CHF1.6 million, according to the mean estimate from 3
analysts, based on Refinitiv data.  
    * ​Refinitiv's mean analyst estimate for AC Immune SA is for
a
loss of 25 rappen per share. 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 3 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for AC Immune
SA is
$9​, above​ its last closing price of $2.19. ​​​

Previous quarterly performance (using preferred earnings measure
in Swiss francs). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Sep. 30 2022  -0.27       -0.24      -0.16     Beat    33.8
 Jun. 30 2022  -0.25       -0.23      -0.23     Met     1
 Mar. 31 2022  -0.22       -0.22      -0.23     Missed  -3.8​
 Dec. 31 2021  0.82        0.10       -0.28     Missed  -373.1
 ​​Sep.        -0.26       -0.27      -0.22     Beat    19.1
 30 2021                                                
 Jun. 30 2021  -0.19       -0.24      -0.26     Missed  -8.2​
 Mar. 31 2021  -0.24       -0.23      -0.23     Met     0.2
 Dec. 31 2020  -0.27       -0.25      -0.27     Missed  -9.2
 This summary was machine generated March 14 at 11:06 GMT.  All
figures in Swiss francs  unless otherwise stated